{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:58:39Z","timestamp":1701392319012},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2000,3,27]],"date-time":"2000-03-27T00:00:00Z","timestamp":954115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,3,27]],"date-time":"2000-03-27T00:00:00Z","timestamp":954115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,4,1]]},"DOI":"10.1038\/sj.bmt.1702239","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:45:26Z","timestamp":1031154326000},"page":"697-703","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies"],"prefix":"10.1038","volume":"25","author":[{"given":"T","family":"Demirer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NM","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"G\u00fcnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"\u00c7elebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Akan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Demirer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ayd\u0131ntu\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,3,27]]},"reference":[{"key":"BF1702239_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1200\/JCO.1990.8.4.638","volume":"8","author":"FB Petersen","year":"1990","unstructured":"Petersen FB, Appelbaum FR, Hill R et al. Autologous marrow transplantation for malignant lymphoma. A report of 101 cases from Seattle J Clin Oncol 1990 8: 638\u2013647","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR2","first-page":"3","volume":"4","author":"NC Gorin","year":"1989","unstructured":"Gorin NC, Aegerter P, Auvert B et al. Autologous bone marrow transplantation (ABMT) for acute leukemia in remission: an analysis of 1322 cases Bone Marrow Transplant 1989 4: (Suppl.2) 3\u20135","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1200\/JCO.1990.8.7.1239","volume":"8","author":"JP Eder","year":"1990","unstructured":"Eder JP, Elias A, Shea TC et al. A phase I\u2013II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients J Clin Oncol 1990 8: 1239\u20131245","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jnci\/82.1.29","volume":"82","author":"JA Moormeier","year":"1990","unstructured":"Moormeier JA, Williams SF, Kaminer LS et al. High-dose tri-alkylator chemotherapy with autologous stem cell rescue in patients with refractory malignancies J Natl Cancer Inst 1990 82: 29\u201334","journal-title":"J Natl Cancer Inst"},{"key":"BF1702239_CR5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/jnci\/80.15.1221","volume":"80","author":"JP Eder","year":"1988","unstructured":"Eder JP, Antman K, Elias A et al. Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors J Natl Cancer Inst 1988 80: 1221\u20131226","journal-title":"J Natl Cancer Inst"},{"key":"BF1702239_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1200\/JCO.1987.5.2.260","volume":"5","author":"SF Williams","year":"1987","unstructured":"Williams SF, Bitran JD, Kaminer L et al. A phase I\u2013II study of bialkylator chemotherapy, high-dose thiotepa and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer J Clin Oncol 1987 5: 260\u2013265","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR7","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/JCO.1986.4.11.1592","volume":"4","author":"JP Eder","year":"1986","unstructured":"Eder JP, Antman K, Peters W et al. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer J Clin Oncol 1986 4: 1592\u20131597","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1200\/JCO.1994.12.1.176","volume":"12","author":"PJ Stiff","year":"1994","unstructured":"Stiff PJ, McKenzie RS, Albert DS et al. Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma J Clin Oncol 1994 12: 176\u2013183","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR9","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1200\/JCO.1997.15.5.1870","volume":"15","author":"K Antman","year":"1997","unstructured":"Antman K, Rowlings PA, Vaughan WP et al. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America J Clin Oncol 1997 15: 1870\u20131879","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR10","first-page":"769","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al. High-dose busulfan, and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer Bone Marrow Transplant 1996 17: 769\u2013774","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR11","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1200\/JCO.1988.6.9.1368","volume":"6","author":"WP Peters","year":"1988","unstructured":"Peters WP, Shpall EJ, Jones RB et al. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer J Clin Oncol 1988 6: 1368\u20131376","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR12","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1200\/JCO.1989.7.12.1824","volume":"7","author":"SF Williams","year":"1989","unstructured":"Williams SF, Mick R, Desser R et al. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer J Clin Oncol 1989 7: 1824\u20131830","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/sj.bmt.1701398","volume":"22","author":"LA Holmberg","year":"1998","unstructured":"Holmberg LA, Demirer T, Rowley S et al. High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III\u2013IV ovarian cancer Bone Marrow Transplant 1998 22: 651\u2013659","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1200\/JCO.1988.6.6.1031","volume":"6","author":"RF Ozols","year":"1988","unstructured":"Ozols RF, Ihde DC, Linehan M et al. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ cell tumors J Clin Oncol 1988 6: 1031\u20131040","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR15","first-page":"689","volume":"71","author":"HM Lazarus","year":"1987","unstructured":"Lazarus HM, Reed MD, Spitzer TR et al. High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer Cancer Treat Rep 1987 71: 689\u2013695","journal-title":"Cancer Treat Rep"},{"key":"BF1702239_CR16","first-page":"2","volume":"17","author":"SN Wolff","year":"1990","unstructured":"Wolff SN, Herzig RH, Fay JW et al. High-dose N, N\u2032, N\u2033-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies Semin Oncol 1990 17: 2\u20136","journal-title":"Semin Oncol"},{"key":"BF1702239_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.1983.1.6.359","volume":"1","author":"HM Lazarus","year":"1983","unstructured":"Lazarus HM, Herzig RH, Graham-Pole J et al. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer J Clin Oncol 1983 1: 359\u2013367","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR18","first-page":"29","volume":"18","author":"T Demirer","year":"1996","unstructured":"Demirer T, Petersen FB, Bensinger WI et al. Autologous transplantation with peripheral blood stem cells collected after granulocyte-colony stimulating factor in patients with acute myelogenous leukemia Bone Marrow Transplant 1996 18: 29\u201334","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1200\/JCO.1988.6.11.1768","volume":"6","author":"G Sarosy","year":"1988","unstructured":"Sarosy G, Leyland-Jones B, Soochan P et al. The systemic administration of intravenous melphalan J Clin Oncol 1988 6: 1768\u20131782","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR20","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1749-6632.1958.tb42651.x","volume":"68","author":"JC Wright","year":"1958","unstructured":"Wright JC, Golomb FM, Gumport SL et al. Summary of results with triethylenethiophosphoramide Ann NY Acad Sci 1958 68: 937\u2013966","journal-title":"Ann NY Acad Sci"},{"key":"BF1702239_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/1097-0142(195301)6:1<135::AID-CNCR2820060113>3.0.CO;2-R","volume":"6","author":"S Farber","year":"1953","unstructured":"Farber S, Appleton R, Downing V et al. Clinical studies on the carcinolytic action of triethylenephosphoramide Cancer 1953 6: 135\u2013141","journal-title":"Cancer"},{"key":"BF1702239_CR22","first-page":"89","volume":"10","author":"CF Lemaistre","year":"1987","unstructured":"Lemaistre CF, Herzig GP, Herzig RH et al. High-dose thiotepa and autologous bone marrow rescue for the treatment of breast cancer Breast Cancer Res Treat 1987 10: 89\u201394","journal-title":"Breast Cancer Res Treat"},{"key":"BF1702239_CR23","first-page":"475","volume-title":"ABMT: Proceedings of the 3rd international symposium","author":"D Maranichi","year":"1987","unstructured":"Maranichi D, Piana L, Blaise D et al. Phase I\u2013II studies of high-dose alkylating agents in poor risk patients with breast cancer with autologous bone marrow transplant. In: Dicke K, Spitzer TR, Jagannath S (eds) ABMT: Proceedings of the 3rd international symposium University of Texas MD Anderson Hospital: Houston, TX 1987 475\u2013480"},{"key":"BF1702239_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/1097-0142(19831115)52:10<1783::AID-CNCR2820521004>3.0.CO;2-H","volume":"52","author":"R Corringham","year":"1983","unstructured":"Corringham R, Gilmore M, Prentice H et al. High-dose melphalan with autologous bone marrow transplant: treatment of poor prognosis tumors Cancer 1983 52: 1783\u20131787","journal-title":"Cancer"},{"key":"BF1702239_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJM195505262522101","volume":"252","author":"JC Bateman","year":"1955","unstructured":"Bateman JC . Chemotherapy of solid tumors with triethylene thiophosphamide New Engl J Med 1955 252: 879\u2013887","journal-title":"New Engl J Med"},{"key":"BF1702239_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/1097-0142(195709\/10)10:5<902::AID-CNCR2820100507>3.0.CO;2-F","volume":"10","author":"JE Ultmann","year":"1957","unstructured":"Ultmann JE, Hyman GA, Crandall C et al. Triethylenephosphoramide (thiotepa) in the treatment of neoplastic disease Cancer 1957 10: 902\u2013911","journal-title":"Cancer"},{"key":"BF1702239_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0305-7372(85)90019-2","volume":"12","author":"RF Ozols","year":"1985","unstructured":"Ozols RF, Behrens BC, Ostchega Y et al. High-dose cisplatin and high-dose carboplatin in refractory ovarian cancer Cancer Treatment Rev 1985 12: 59\u201362","journal-title":"Cancer Treatment Rev"},{"key":"BF1702239_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1200\/JCO.1989.7.5.651","volume":"7","author":"TC Shea","year":"1989","unstructured":"Shea TC, Flaherty M, Elias A et al. A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support J Clin Oncol 1989 7: 651\u2013655","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1200\/JCO.1992.10.1.102","volume":"10","author":"K Antman","year":"1992","unstructured":"Antman K, Ayash L, Elias A et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy J Clin Oncol 1992 10: 102\u2013110","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1200\/JCO.1996.14.4.1156","volume":"14","author":"K Holland","year":"1996","unstructured":"Holland K, Dix SP, Geller RB et al. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow\/stem-cell transplantation and comprehensive supportive care J Clin Oncol 1996 14: 1156\u20131164","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1200\/JCO.1998.16.3.1000","volume":"16","author":"L Ayash","year":"1998","unstructured":"Ayash L, Elias A, Ibrahim J et al. High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma J Clin Oncol 1998 16: 1000\u20131007","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR32","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.1995.13.7.1714","volume":"13","author":"T Demirer","year":"1995","unstructured":"Demirer T, Buckner CD, Bensinger WI et al. Peripheral blood stem cell (PBSC) collections after taxol, cyclophosphamide and recombinant human granulocyte-colony-stimulating factor (rhG-CSF) J Clin Oncol 1995 13: 1714\u20131719","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/stem.140106","volume":"14","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Bensinger WI et al. Optimization of peripheral blood stem cell mobilization Stem Cells 1996 14: 106\u2013116","journal-title":"Stem Cells"},{"key":"BF1702239_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1200\/JCO.1997.15.2.684","volume":"15","author":"T Demirer","year":"1997","unstructured":"Demirer T, Buckner CD, Storer B et al. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte-colony stimulating factor J Clin Oncol 1997 15: 684\u2013690","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/106161299320389","volume":"8","author":"T Demirer","year":"1999","unstructured":"Demirer T, Bensinger WI, Buckner CD . Peripheral blood stem cell mobilization for high-dose chemotherapy J Hematother 1999 8: 103\u2013113","journal-title":"J Hematother"},{"key":"BF1702239_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1046\/j.1537-2995.1997.37997454014.x","volume":"37","author":"CH Weaver","year":"1997","unstructured":"Weaver CH, Schwartzberg LS, Birch R et al. Collection of peripheral blood progenitor cells following the administration of cyclophosphamide, etoposide and granulocyte-colony stimulating factor: an analysis of 497 patients Transfusion 1997 37: 896\u2013903","journal-title":"Transfusion"},{"key":"BF1702239_CR37","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V81.11.3158.3158","volume":"81","author":"W Bensinger","year":"1993","unstructured":"Bensinger W, Singer J, Appelbaum FR et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte-stimulating factor Blood 1993 81: 3158\u20133163","journal-title":"Blood"},{"key":"BF1702239_CR38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V36.4.507.507","volume":"36","author":"ED Thomas","year":"1970","unstructured":"Thomas ED, Storb R . Technique for human marrow grafting Blood 1970 36: 507\u2013515","journal-title":"Blood"},{"key":"BF1702239_CR39","first-page":"pp355","volume-title":"Organ Preservation for Transplantation","author":"CD Buckner","year":"1981","unstructured":"Buckner CD, Appelbaum FR, Thomas ED . Bone marrow and fetal liver. In: Karow AM Jr, Pegg DE (eds) Organ Preservation for Transplantation Marcel Dekker: New York 1981 pp355\u2013375"},{"key":"BF1702239_CR40","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD et al. Regimen related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 1988 6: 1562\u20131568","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/01621459.1969.10500960","volume":"64","author":"BP Hsi","year":"1969","unstructured":"Hsi BP . The multiple sample up-and-down method in bioassay J Am Stat Assoc 1969 64: 147\u2013162","journal-title":"J Am Stat Assoc"},{"key":"BF1702239_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","volume":"69","author":"III Frei E","year":"1986","unstructured":"Frei E III, Canellos GP . Dose: a critical factor in cancer chemotherapy Am J Med 1986 69: 585\u2013599","journal-title":"Am J Med"},{"key":"BF1702239_CR43","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1073\/pnas.82.7.2158","volume":"82","author":"III Frei E","year":"1985","unstructured":"Frei E III, Cucchi GA, Rosowsky A et al. Alkylating agents resistance: in vitro studies with human cell lines Proc Natl Acad Sci USA 1985 82: 2158\u20132162","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1702239_CR44","doi-asserted-by":"publisher","first-page":"pp69","DOI":"10.1016\/B978-0-12-763362-6.50012-1","volume-title":"Mechanism of Drug Resistance in Neoplastic Cells","author":"III Frei E","year":"1988","unstructured":"Frei E III, Teicher B, Cucchi GA et al. Resistance to alkylating agents: basic studies and therapeutic implications. In: Wooley P III, Tew K (eds) Mechanism of Drug Resistance in Neoplastic Cells Academic Press: New York 1988 pp69\u201387"},{"key":"BF1702239_CR45","first-page":"65","volume":"14","author":"WM Hyrniuk","year":"1987","unstructured":"Hyrniuk WM . Relative dose intensity and the impact on design of clinical trials Semin Oncol 1987 14: 65\u201374","journal-title":"Semin Oncol"},{"key":"BF1702239_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0305-7372(74)80002-2","volume":"1","author":"LE Broder","year":"1974","unstructured":"Broder LE, Tormey DC . Combination chemotherapy of carcinoma of the breast cancer Cancer Treat Rev 1974 1: 183\u2013203","journal-title":"Cancer Treat Rev"},{"key":"BF1702239_CR47","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function J Clin Oncol 1989 7: 1748","journal-title":"J Clin Oncol"},{"key":"BF1702239_CR48","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/sj.bmt.1700976","volume":"20","author":"CH Weaver","year":"1997","unstructured":"Weaver CH, Greco FA, Hainsworth J et al. A phase I\u2013II study of high-dose melphalan, mitoxantrone and carboplatin with PBSC support in patients with advanced ovarian or breast carcinoma Bone Marrow Transplant 1997 20: 847\u2013853","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR49","first-page":"813","volume":"14","author":"CH Weaver","year":"1994","unstructured":"Weaver CH, Bensinger WI, Appelbaum FR et al. Phase I study of high-dose busulfan, melphalan, and thiotepa with autologous stem cell support in patients with refractory malignancies Bone Marrow Transplant 1994 14: 813\u2013819","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR50","first-page":"323","volume":"12","author":"A Srivastava","year":"1993","unstructured":"Srivastava A, Bradstock KF, Szer J et al. Busulfan and melphalan prior to autologous bone marrow transplantation Bone Marrow Transplant 1993 12: 323\u2013329","journal-title":"Bone Marrow Transplant"},{"key":"BF1702239_CR51","first-page":"261","volume":"3","author":"K Schiffman","year":"1997","unstructured":"Schiffman K, Buckner CD, Maziarz R et al. High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease Biol Blood Marrow Transplant 1997 3: 261\u2013266","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702239","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:26:38Z","timestamp":1648070798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,27]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,4,1]]}},"alternative-id":["BF1702239"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702239","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3,27]]},"assertion":[{"value":"7 September 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}